Open Access

MicroRNA‑212 facilitates the motility and invasiveness of esophageal squamous carcinoma cells

  • Authors:
    • Zhi Chen
    • Yuzhen Liu
    • Bo Qi
    • Chengwei Gu
    • Xiufeng Wei
    • Ling Guo
    • Wenjian Yao
    • Baosheng Zhao
  • View Affiliations

  • Published online on: September 3, 2019     https://doi.org/10.3892/mmr.2019.10647
  • Pages: 3633-3641
  • Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

As a tumor‑associated microRNA (miR), miR‑212 has dual functions; either as an oncogene or a tumor suppressor. A high expression level of miR‑212 was reported to be associated with poor outcome in patients with esophageal squamous cell carcinoma (ESCC), however, its role in ESCC progression has not been explored. In the present study, an in vitro cell model of lentivirus‑mediated gain‑of‑function demonstrated promotion of ESCC cell migration and invasion when miR‑212 was overexpressed, and no effect on cell proliferation. miR‑212 resulted in downregulation of the expression of E‑cadherin, β‑catenin, vimentin and Twist1. Moreover, it led to increased levels of extracellular matrix (ECM)‑degrading enzymes, matrix metalloproteinase‑9 and urokinase‑type plasminogen activator. Furthermore, berberine inhibited miR‑212‑induced ESCC cell migration, unlike the PI3K inhibitor LY294002, rapamycin (mTOR inhibitor), 5‑(Tetradecyloxy)‑2‑furoic acid (TOFA; an acetyl‑CoA carboxylase 1 inhibitor), metformin and propranolol. These data suggest that miR‑212 activates multiple signaling cascades and facilitates ESCC cell motility and invasion by promoting the epithelial‑mesenchymal transition and degrading the ECM. Berberine may be a potential therapeutic agent against metastasis in patients with ESCC, who express high levels of miR‑212.

References

1 

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Arnold M, Soerjomataram l, Ferlay J and Forman D: Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 64:381–387. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Murphy G, McCormack V, Abedi-Ardekani B, Arnold M, Camargo MC, Dar NA, Dawsey SM, Etemadi A, Fitzgerald RC, Fleischer DE, et al: International cancer seminars: A focus on esophageal squamous cell carcinoma. Ann Oncol. 28:2086–2093. 2017. View Article : Google Scholar : PubMed/NCBI

4 

Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu L and He J: Report of incidence and mortality in China cancer registries, 2009. Chin J Cancer Res. 25:10–21. 2013.PubMed/NCBI

5 

Cheng J, Jin H, Hou X, Lv J, Gao X and Zheng G: Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma. Biochem Biophys Res Commun. 486:781–787. 2017. View Article : Google Scholar : PubMed/NCBI

6 

Croce CM: Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009. View Article : Google Scholar : PubMed/NCBI

7 

Bracken CP, Scott HS and Goodall GJ: A network-biology perspective of microRNA function and dysfunction in cancer. Nat Rev Genet. 17:719–732. 2016. View Article : Google Scholar : PubMed/NCBI

8 

Sakai NS, Samia-Aly E, Barbera M and Fitzgerald RC: A review of the current understanding and clinical utility of miRNAs in esophageal cancer. Semin Cancer Biol. 23:512–521. 2013. View Article : Google Scholar : PubMed/NCBI

9 

Harada K, Baba Y, Ishimoto T, Shigaki H, Kosumi K, Yoshida N, Watanabe M and Baba H: The role of microRNA in esophageal squamous cell carcinoma. J Gastroenterol. 51:520–530. 2016. View Article : Google Scholar : PubMed/NCBI

10 

Zhao BS, Liu SG, Wang TY, Ji YH, Qi B, Tao YP, Li HC and Wu XN: Screening of microRNA in patients with esophageal cancer at same tumor node metastasis stage with different prognoses. Asian Pac J Cancer Prev. 14:139–143. 2013. View Article : Google Scholar : PubMed/NCBI

11 

Qi B, Liu SG, Qin XG, Yao WJ, Lu JG, Guo L, Wang TY, Li HC and Zhao BS: Overregulation of microRNA-212 in the poor prognosis of esophageal cancer patients. Genet Mol Res. 13:7800–7807. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Li B, Li J, Xu WW, Guan XY, Qin XY, Zhang LY, Law S, Tsao SW and Cheung AL: Suppression of esophageal tumor growth and chemoresistance by directly targeting the PI3K/Akt pathway. Oncotarget. 5:11576–11587. 2014.PubMed/NCBI

13 

Lu Z, Peng K, Wang N, Liu HM and Hou G: Downregulation of p70S6K enhances cell sensitivity to rapamycin in esophageal squamous cell carcinoma. J Immunol Res. 2016:78289162016. View Article : Google Scholar : PubMed/NCBI

14 

Medina EA, Obertheu K, Polusani SR, Ortega V, Velagaleti GV and Oyajobi BO: PKA/AMPK signaling in relation to adiponectin's antiproliferative effect on multiple myeloma cells. Leukemia. 28:2080–2089. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Liang F, Wang YG and Wang C: Metformin inhibited growth, invasion and metastasis of esophageal squamous cell carcinoma in vitro and in vivo. Cell Physiol Biochem. 51:1276–1286. 2018. View Article : Google Scholar : PubMed/NCBI

16 

Chen YZ, Bai N, Bi JH, Liu XW, Xu Go, Zhang LF, Li XQ and Huo R: Propranolol inhibits the proliferation, migration and tube formation of hemangioma cells through HIF-1α dependent mechanisms. Braz J Med Biol Res. 50:e61382017. View Article : Google Scholar : PubMed/NCBI

17 

Jiang SX, Qi B, Yao WJ, Gu CW, Wei XF, Zhao Y, Liu YZ and Zhao BS: Berberine displays antitumor activity in esophageal cancer cells in vitro. World J Gastroenterol. 23:2511–2518. 2017. View Article : Google Scholar : PubMed/NCBI

18 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Method. 5:402–408. 2001. View Article : Google Scholar

19 

Thiery JP, Acloque H, Huang RY and Nieto MA: Epithelial- mesenchymal transitions in development and disease. Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI

20 

Baker EA, Stephenson TJ, Reed MW and Brown NJ: Expression of proteinases and inhibitors in human breast cancer progression and survival. Mol Pathol. 55:300–304. 2002. View Article : Google Scholar : PubMed/NCBI

21 

Rao JS, Gondi C, Chetty C, Chittivelu S, Joseph PA and Lakka SS: Inhibition of invasion, angiogenesis, tumor growth and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells. Mol Cancer Ther. 4:1399–1408. 2005. View Article : Google Scholar : PubMed/NCBI

22 

Wang YY, Tang LQ and Wei W: Berberine attenuates podocytes injury caused by exosomes derived from high glucose-induced mesangial cells through TGFβ1-PI3K/AKT pathway. Eur J Pharmacol. 824:185–192. 2018. View Article : Google Scholar : PubMed/NCBI

23 

Mishan MA, Ahmadiankia N, Matin MM, Heirani-Tabasi A, Shahriyari M, Bidkhori HR, Naderi-Meshkin H and Bahrami AR: Role of berberine on molecular markers involved in migration of esophageal cancer cells. Cell Mol Biol (Noisy-le-grand). 61:37–43. 2015.PubMed/NCBI

24 

Chen CZ: MicroRNAs as oncogenes and tumor suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI

25 

Remenyi J, vanden Bosch MW, Palygin O, Mistry RB, McKenzie C, Macdonald A, Hutvagner G, Arthur JS, Frenguelli BG and Pankratov Y: miR-132/212 Knockout mice reveal roles for these miRNAs in regulating cortical synaptic transmission and plasticity. PLoS One. 8:e625092013. View Article : Google Scholar : PubMed/NCBI

26 

Remenyi J, Hunter CJ, Cole C, Ando H, Impey S, Monk CE, Martin KJ, Barton GJ, Hutvagner G and Arthur JS: Regulation of the miR-212/132 locus by MSK1 and CREB in response to neurotrophins. Biochem J. 428:281–291. 2010. View Article : Google Scholar : PubMed/NCBI

27 

Jiping Z, Ming F, Lixiang W, Xiuming L, Yuqun S, Han Y, Zhifang L, Yundong S, Shili L, Chunyan C and Jihui J: MicroRNA-212 inhibits proliferation of gastric cancer by directly repressing retinoblastoma binding protein 2. J Cell Biochem. 114:2666–2272. 2013. View Article : Google Scholar : PubMed/NCBI

28 

Roomi MW, Kalinovsky T, Niedzwiecki A and Rath M: Modulation of uPA, MMPs and their inhibitors by a novel nutrient mixture in human colorectal, pancreatic and hepatic carcinoma cell lines. Int J Oncol. 47:370–376. 2015. View Article : Google Scholar : PubMed/NCBI

29 

Yamashita K, Tanaka Y, Mimori K, Inoue H and Mori M: Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma. Int J Cancer. 110:201–207. 2004. View Article : Google Scholar : PubMed/NCBI

30 

Yan C and Boyd DD: Regulation of matrix metalloproteinase gene expression. J Cell physiol. 211:19–26. 2007. View Article : Google Scholar : PubMed/NCBI

31 

Chakraborti S, Mandal M, Das S, Mandal A and Chakraborti T: Regulation of matrix metalloproteinases: An overview. Mol Cell Biochem. 253:269–285. 2003. View Article : Google Scholar : PubMed/NCBI

32 

Kou Y, Li L, Li H, Tan Y, Li B, Wang K and Du B: Berberine suppressed epithelial mesenchymal transition through cross-talk regulation of PI3K/AKT and RARα/RARβ in melanoma cells. Biochem Biophys Res Commun. 479:290–296. 2016. View Article : Google Scholar : PubMed/NCBI

33 

Li L, Wang X, Sharvan R, Gao J and Qu S: Berberine could inhibit thyroid carcinoma cells by inducing mitochondrial apoptosis, G0/G1 cell cycle arrest and suppressing migration via PI3K-AKT and MAPK signaling pathways. Biomed Pharmacother. 95:1225–1231. 2017. View Article : Google Scholar : PubMed/NCBI

34 

Ai F, Chen M, Yu B, Yang Y, Xu G, Gui F, Liu Z, Bai X and Chen Z: Berberine regulates proliferation, collagen synthesis and cytokine secretion of cardiac fibroblasts via AMPK-mTOR-p70S6K signaling pathway. Int J Clin Exp Pathol. 8:12509–12516. 2015.PubMed/NCBI

35 

Kim HS, Kim MJ, Kim EJ, Yang Y, Lee MS and Lim JS: Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression. Biochem Pharmacol. 83:385–394. 2012. View Article : Google Scholar : PubMed/NCBI

36 

Xie M, Fu Z, Cao J, Liu Y, Wu J, Li Q and Chen Y: MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer. Biomed Pharmacother. 102:286–294. 2018. View Article : Google Scholar : PubMed/NCBI

37 

Fu W, Tao T, Qi M, Wang L, Hu J, Li X, Xing N, Du R and Han B: MicroRNA-132/212 upregulation inhibits TGF-β-mediated epithelial-mesenchymal transition of prostate cancer cells by targeting SOX4. Prostate. 76:1560–1570. 2016. View Article : Google Scholar : PubMed/NCBI

38 

Ma C, Nong K, Wu B, Dong B, Bai Y, Zhu H, Wang W, Huang X, Yuan Z and Ai K: miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1. J Exp Clin Cancer Res. 33:542014. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

October 2019
Volume 20 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Chen, Z., Liu, Y., Qi, B., Gu, C., Wei, X., Guo, L. ... Zhao, B. (2019). MicroRNA‑212 facilitates the motility and invasiveness of esophageal squamous carcinoma cells. Molecular Medicine Reports, 20, 3633-3641. https://doi.org/10.3892/mmr.2019.10647
MLA
Chen, Z., Liu, Y., Qi, B., Gu, C., Wei, X., Guo, L., Yao, W., Zhao, B."MicroRNA‑212 facilitates the motility and invasiveness of esophageal squamous carcinoma cells". Molecular Medicine Reports 20.4 (2019): 3633-3641.
Chicago
Chen, Z., Liu, Y., Qi, B., Gu, C., Wei, X., Guo, L., Yao, W., Zhao, B."MicroRNA‑212 facilitates the motility and invasiveness of esophageal squamous carcinoma cells". Molecular Medicine Reports 20, no. 4 (2019): 3633-3641. https://doi.org/10.3892/mmr.2019.10647